Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Details Narrative)

v3.2.0.727
Basis of Presentation and Significant Accounting Policies (Details Narrative)
 3 Months Ended 6 Months Ended
Apr. 08, 2015
USD ($)
Mar. 09, 2015
USD ($)
Jun. 30, 2015
USD ($)
shares
Jun. 30, 2014
USD ($)
shares
Jun. 30, 2015
USD ($)
Breathlyzers
shares
Jun. 30, 2014
USD ($)
shares
Dec. 31, 2014
USD ($)
Allowance for doubtful accounts receivable     $ 864,000   $ 864,000    
Accounts receivable     1,000,000   1,000,000   $ 1,000,000
Accounts receivable due     $ 864,000   $ 864,000    
Impairment or disposal of long-lived assets              
Investment in Hainan Savy Akers Biosciences, Ltd. joint venture $ 64,091 $ 64,675          
Percentage of ownership in Hainan Savy Akers Biosciences, Ltd. joint venture     19.90%   19.90%    
Deferred revenue     $ 291,869   $ 291,869    
Revenue from related parties       $ 864,000   $ 1,630,379  
Shipping, handling and transportation costs     $ 13,836 8,999 $ 32,778 17,237  
Net Loss Attributable to Common Stockholders     $ 2,086,229 $ 510,788 $ 3,408,028 $ 1,106,388  
Option [Member]              
Antidilutive securities excluded from computation of earnings per share | shares     175,000   175,000    
Warrant [Member]              
Antidilutive securities excluded from computation of earnings per share | shares       1,989   1,989  
Cost of Sales [Member]              
Shipping, handling and transportation costs     $ 22,716 $ 18,170 $ 67,406 $ 29,207  
Increment One Paid on April 30, 2015 [Member] | April Payment Paid on August 12, 2015 [Member]              
Accounts receivable     500,000   500,000    
Increment Two Paid on July 30, 2015 [Member]              
Accounts receivable     500,000   $ 500,000    
Trade Receivable [Member]              
Concentration risk percentage         79.00%    
Concentration risk, number of customer | Breathlyzers         3    
Percentage of customer accounted for trade receivables         30.00%    
Fulton Bank of New Jersey [Member]              
Cash     173,196   $ 173,196   399,417
Bank of America [Member]              
Cash     83,998   83,998   52,384
PayPal [Member]              
Cash     $ 4,040   $ 4,040   $ 4,040
Rapid Enzymatic Assay [Member]              
Revenue from related parties       864,000      
Minimum [Member]              
Normal credit terms extended to customers         30 days    
Maximum [Member]              
Normal credit terms extended to customers         90 days    
Cash, FDIC insured amount       $ 250,000   $ 250,000  
Maximum [Member] | Patents [Member]              
Finite-lived intangible asset, useful life         17 years